BeOne Medicines AG (ONC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.58B
Last updated: Nov 17, 2026 at 11:05 AM ET
BeOne Medicines AG (ONC) Competitors
The companies most similar to BeOne Medicines AG are Genmab AS (GMAB), argenx NV ADR (ARGX) and Regeneron Pharmaceuticals (REGN). BeOne Medicines AG trades at 50.0x earnings, against a median of 30.0x for the 7 of these companies with a P/E. By market cap, BeOne Medicines AG ranks 5th of the 13 companies on this page; Vertex Pharmaceuticals (VRTX) is the largest at $136.56B.
Peer Comparison
ONC's ROIC of 7.5% is above the peer median of 4.8%, and its revenue growth of 33.8% is above the median of 32.8%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| BeOne Medicines AG (ONC) | $47.58B | 50.0x | 18.7x | 13.9% | 7.5% | 33.8% | 0.00% |
| Genmab AS (GMAB) | $31.67B | 35.8x | 19.2x | 17.0% | 4.8% | 16.1% | 0.00% |
| argenx NV ADR (ARGX) | $60.37B | 33.5x | 6.1x | 31.7% | N/A | 52.1% | 0.00% |
| Regeneron Pharmaceuticals Inc (REGN) | $98.84B | 18.4x | 5.7x | 28.5% | 13.7% | 36.3% | 0.39% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Revolution Medicines Inc (RVMD) | $37.27B | N/A | 181.6x | 0.0% | -52.1% | -95.2% | 0.00% |
| Royalty Pharma Plc (RPRX) | $39.85B | 12.9x | 11.7x | 25.7% | 7.6% | 13.3% | 1.37% |
| Insmed Inc (INSM) | $26.58B | N/A | 17.7x | -39.9% | -44.2% | 268.4% | 0.00% |
| Roivant Sciences Ltd (ROIV) | $28.64B | N/A | 679.3x | 0.0% | N/A | 2136.0% | 0.00% |
| Moderna Inc (MRNA) | $90.38B | N/A | 34.2x | -110.5% | -28.9% | 29.2% | 0.00% |
| Exelixis Inc (EXEL) | $16.84B | 19.3x | 6.9x | 35.4% | N/A | 10.2% | 0.00% |
| Vertex Pharmaceuticals Inc (VRTX) | $136.56B | 30.0x | 10.5x | 30.7% | 14.2% | 11.8% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Peer median | $34.47B | 30.0x | 13.9x | 14.4% | 4.8% | 32.8% | 0.00% |
Similar Companies
These are the 12 companies most similar to BeOne Medicines AG, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Genmab AS (GMAB) | Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark. | GMAB competitors |
| argenx NV ADR (ARGX) | argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases... | ARGX competitors |
| Regeneron Pharmaceuticals Inc (REGN) | Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. | REGN competitors |
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| Revolution Medicines Inc (RVMD) | Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted... | RVMD competitors |
| Royalty Pharma Plc (RPRX) | Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. | RPRX competitors |
| Insmed Inc (INSM) | Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. | INSM competitors |
| Roivant Sciences Ltd (ROIV) | Roivant Sciences Ltd (ROIV) is a transformative biopharmaceutical company focused on advancing drug development and commercialization through a distinctive... | ROIV competitors |
| Moderna Inc (MRNA) | Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology... | MRNA competitors |
| Exelixis Inc (EXEL) | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development... | EXEL competitors |
| Vertex Pharmaceuticals Inc (VRTX) | Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. | VRTX competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
Frequently Asked Questions About ONC
Who are BeOne Medicines AG's main competitors?
The companies most similar to BeOne Medicines AG include Genmab AS (GMAB), argenx NV ADR (ARGX), Regeneron Pharmaceuticals (REGN), BridgeBio Pharma (BBIO) and Revolution Medicines (RVMD), listed from the closest match.
Who is BeOne Medicines AG's biggest competitor?
Vertex Pharmaceuticals (VRTX) is the largest of the similar companies at $136.56B; Genmab AS (GMAB) is the closest match by business profile, size, sector and industry.
How does ONC stock compare with its competitors?
ONC's P/E is 50.0x against a peer median of 30.0x; its P/S is 18.7x against a peer median of 13.9x; its net margin is 13.9% against a peer median of 14.4%.
Which of BeOne Medicines AG's competitors pays a higher dividend?
BeOne Medicines AG pays no dividend. Royalty Pharma Plc (RPRX) and Regeneron Pharmaceuticals (REGN) have higher forward dividend yields; Royalty Pharma Plc (RPRX) has the highest at 1.37%.
Is BeOne Medicines AG bigger than its competitors?
No. BeOne Medicines AG is 5th by market cap among the 13 companies on this page; the largest is Vertex Pharmaceuticals (VRTX) at $136.56B.
ONC pages: Overview, Valuation, Competitors